2022
DOI: 10.1164/rccm.202201-0142oc
|View full text |Cite
|
Sign up to set email alerts
|

Impairment of the NKT–STAT1–CXCL9 Axis Contributes to Vessel Fibrosis in Pulmonary Hypertension Caused by Lung Fibrosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
10
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 23 publications
(10 citation statements)
references
References 58 publications
0
10
0
Order By: Relevance
“…CEACAM1 [340], ACSL1 [341], TLR4 [342], ABCA1 [343], TLR5 [344], CYP2D6 [345], JAK2 [346], NOTCH2 [347], DDX3X [348], NCOA4 [349], EGR1 [350], IQGAP2 [351], GCLC (glutamate-cysteine ligase catalytic subunit) [352], VEGFA (vascular endothelial growth factor A) [353], ITGB1 [354], LDLR (low density lipoprotein receptor) [355], TLR6 [316], SIRT1 [356], FGL2 [357], TET2 [358], PHF2 [328], VEGFB (vascular endothelial growth factor B) [359], SELENOM (selenoprotein M) [360], TRPM4 [361], OLFM2 [362] and ATAD3A [363] are thought to be involved in non-alcoholic fatty liver disease. Altered expression of ATOH8 [364], STAT1 [365], ARG1 [366], TLR4 [367], VNN1 [368], ABCA1 [369], IFIH1 [370], PTGS2 [371], F2RL1 [289], CYP2D6 [372], PDK4 [373], RNF213 [374], JAK2 [375], NOTCH2 [376], PDGFC (platelet derived growth factor C) [377], TLR2 [378], CYP1B1 [379], IL1RN [380], GCH1 [381], EGR1 [382], HIF1A [383], PLA2G7 [384], CCR2 [385], GAB1 [386], VEGFA (vascular endothelial growth factor A) [387], OGT (O-linked N-acetylglucosamine (GlcNAc) transferase) [388], OXR1 [389], IRF9 [390], FMR1 [391], LDLR (low density lipoprotein receptor) [392], SIRT1 [393], NOD2 [394], ATP13A3 [395], VCAN (versican) [396], FGL2 [397], TET2 [398], KDM6A [399], KLHL2 [400], CAVIN1 [401], TNFRSF4 [402], PF4 [403], VEGFB (vascular endothelial growth factor B) [330], CCR7 [404], PRDX2 [405], HSPB1 [406], TCF4 […”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…CEACAM1 [340], ACSL1 [341], TLR4 [342], ABCA1 [343], TLR5 [344], CYP2D6 [345], JAK2 [346], NOTCH2 [347], DDX3X [348], NCOA4 [349], EGR1 [350], IQGAP2 [351], GCLC (glutamate-cysteine ligase catalytic subunit) [352], VEGFA (vascular endothelial growth factor A) [353], ITGB1 [354], LDLR (low density lipoprotein receptor) [355], TLR6 [316], SIRT1 [356], FGL2 [357], TET2 [358], PHF2 [328], VEGFB (vascular endothelial growth factor B) [359], SELENOM (selenoprotein M) [360], TRPM4 [361], OLFM2 [362] and ATAD3A [363] are thought to be involved in non-alcoholic fatty liver disease. Altered expression of ATOH8 [364], STAT1 [365], ARG1 [366], TLR4 [367], VNN1 [368], ABCA1 [369], IFIH1 [370], PTGS2 [371], F2RL1 [289], CYP2D6 [372], PDK4 [373], RNF213 [374], JAK2 [375], NOTCH2 [376], PDGFC (platelet derived growth factor C) [377], TLR2 [378], CYP1B1 [379], IL1RN [380], GCH1 [381], EGR1 [382], HIF1A [383], PLA2G7 [384], CCR2 [385], GAB1 [386], VEGFA (vascular endothelial growth factor A) [387], OGT (O-linked N-acetylglucosamine (GlcNAc) transferase) [388], OXR1 [389], IRF9 [390], FMR1 [391], LDLR (low density lipoprotein receptor) [392], SIRT1 [393], NOD2 [394], ATP13A3 [395], VCAN (versican) [396], FGL2 [397], TET2 [398], KDM6A [399], KLHL2 [400], CAVIN1 [401], TNFRSF4 [402], PF4 [403], VEGFB (vascular endothelial growth factor B) [330], CCR7 [404], PRDX2 [405], HSPB1 [406], TCF4 […”
Section: Discussionmentioning
confidence: 99%
“…Studies have confirmed that EGR1 [350] and SIRT1 [356] are altered expressed in non-alcoholic fatty liver disease. Previous studies have shown that EGR1 [382], SIRT1 [393], STAT1 [365], HIF1A [383] and IRF9 [390] might influence the prognosis in hypertension. EGR1 [449], SIRT1 [458] and STAT1 [435] are a genes which plays a role in diagnosis of CAD.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Notably, the depletion of MCs in experimental PAH, as well as inhibition of their activity, attenuates pulmonary vascular remodeling [28][29][30][31] . Regulatory T cells (Tregs), natural killer (NK) cells, and NKT cells appear to play a beneficial role in the maintenance of vascular homeostasis and their deficiency and altered function have been linked to PA remodeling and fibrosis [32][33][34][35] . Experimental and clinical PAH is also accompanied by increased numbers and activation of dendritic cells (DCs) and macrophages in remodeled vessels [10,36,37] .…”
Section: Immune Dysregulation In Phmentioning
confidence: 99%
“…In this issue of the Journal , Jandl and colleagues (pp. 981–998 ) describe a novel link between natural killer T (NKT) cell deficiency and pulmonary vascular fibrosis ( 7 ). Perivascular type I collagen deposition was increased in lung tissue from patients with PH-ILD, a cohort composed mainly of patients with idiopathic pulmonary fibrosis, chronic hypersensitivity pneumonitis, and unclassified ILD, compared to samples from ILD patients without PH and donor lung controls.…”
mentioning
confidence: 99%